FILIPPOU, GEORGIOS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 347
NA - Nord America 297
AS - Asia 66
OC - Oceania 2
SA - Sud America 2
Totale 714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 290
IE - Irlanda 125
IT - Italia 99
RU - Federazione Russa 55
SE - Svezia 35
SG - Singapore 25
HK - Hong Kong 21
DE - Germania 20
CN - Cina 16
GB - Regno Unito 10
CA - Canada 5
JP - Giappone 4
AR - Argentina 2
MX - Messico 2
NZ - Nuova Zelanda 2
UA - Ucraina 2
NL - Olanda 1
Totale 714
Salva come PNG Salva come JPEG
Città #
Dublin 96
Moscow 55
Altamura 50
Lawrence 50
Fairfield 43
Menlo Park 35
Boston 30
Princeton 30
Wilmington 20
Guangzhou 16
Singapore 13
Woodbridge 12
Milan 11
Houston 8
San Diego 7
Seattle 7
Norwalk 6
Toronto 5
Cambridge 4
London 4
Shibasaki 4
Albenga 3
Andover 3
Medford 3
Nuremberg 3
Pisa 3
Ashburn 2
Dunedin 2
Florence 2
Hillsboro 2
Hong Kong 2
Lecce 2
Medesano 2
Obregon 2
Portland 2
Ravenna 2
Rome 2
Taranto 2
Trumbull 2
Turin 2
Villa Mercedes 2
Yonkers 2
Acton 1
Ann Arbor 1
Busto Arsizio 1
Chiswick 1
Council Bluffs 1
Esslingen am Neckar 1
Falls Church 1
Ferrara di Monte Baldo 1
Laurel 1
Los Angeles 1
Naaldwijk 1
New Bedfont 1
San Mateo 1
Totale 566
Salva come PNG Salva come JPEG
Nome #
Accuracy of synovial fluid analysis compared to histology for the identification of calcium pyrophosphate crystals: An ancillary study of the OMERACT US working group - CPPD subgroup 49
The two faces of the same medal… or maybe not? Comparing osteoarthritis and calcium pyrophosphate deposition disease: a laboratory and ultrasonographic study 47
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group 39
Very low prevalence of ultrasound-detected tenosynovial abnormalities in healthy subjects throughout the age range: OMERACT ultrasound minimal disease study 37
One-year efficacy and safety of single or one to three weekly injections of hylan G-F 20 for knee osteoarthritis: a systematic literature review and meta-analysis 32
Differential diagnosis of inflammatory arthropathies by musculoskeletal ultrasonography: A systematic literature review 28
IS ULTRASOUND A GOOD TOOL TO EVALUATE CPPD? 28
Identifying potential classification criteria for calcium pyrophosphate deposition disease (CPPD): Item generation and item reduction 27
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group 26
Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: Reliability of the OMERACT definitions in an extended set of joints - An international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force 26
A critical review of the available evidence on the diagnosis and clinical features of CPPD: do we really need imaging? 25
AB0598 EFFICACY OF ULTRASOUND GUIDED INJECTIONS OF A CROSS-LINKED SODIUM HYALURONATE COMBINED WITH TRIAMCINOLONE HEXACETONIDE FOR OSTEOARTHRITIS OF THE KNEE 24
RELIABILITY OF CONVENTIONAL RADIOGRAPHY OF THE KNEE FOR THE ASSESSMENT OF CHONDROCALCINOSIS: AN ANCILLARY STUDY OF THE OMERACT ULTRASOUND – CPPD GROUP 23
Radiomics-Based Assessment of Primary Sjögren's Syndrome from Salivary Gland Ultrasonography Images 23
ASSESSING RELEVANT JOINTS FOR MONITORING CPPD DISEASE: A SYSTEMATIC LITERATURE REVIEW OF IMAGING TECHNIQUES BY THE OMERACT ULTRASOUND – CPPD SUBGROUP 22
AB0629 ACCURACY OF SYNOVIAL FLUID ANALYSIS FOR THE IDENTIFICATION OF CALCIUM PYROPHOSPHATE CRYSTALS: AN ANCILLARY STUDY OF OMERACT CRITERION VALIDITY STUDY FOR ULTRASOUND IN CPPD 22
The diagnostic value of conventional radiography and musculoskeletal ultrasonography in calcium pyrophosphate deposition disease: a systematic literature review and meta-analysis 22
Utility of Ultrasound and Dual Energy CT in Crystal Disease Diagnosis and Management 22
EFFICACY AND SAFETY OF US-GUIDED INJECTIONS OF THE KNEES WITH HYALURONIC ACID IN PATIENTS AFFECTED BY OSTEOARTHRITIS ASSOCIATED TO CALCIUM PYROPHOSPHATE DEPOSITION DISEASE: PRELIMINARY RESULTS 22
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout 22
Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise 21
Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study 21
ACCURACY OF THE OMERACT DEFINITIONS FOR IDENTIFICATION OF CALCIUM PYROPHOSPHATE CRYSTALS WITH ULTRASOUND: FINAL RESULTS OF THE OMERACT US IN CPPD SUB-TASK FORCE STUDY 21
DIAGNOSTIC ACCURACY OF CONVENTIONAL RADIOGRAPHY OF THE KNEE FOR CALCIUM PYROPHOSPHATE DEPOSITION DISEASE: AN ANCILLARY STUDY OF THE OMERACT ULTRASOUND – CPPD GROUP 20
IDENTIFYING POTENTIAL CLASSIFICATION CRITERIA FOR CALCIUM PYROPHOSPHATE DEPOSITION DISEASE (CPPD): RESULTS FROM THE INITIAL PHASES 19
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group 18
Diffuse idiopathic skeletal hyperostosis: a review 17
The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout 17
RS3PE and the role of ultrasound. A case report and brief review of the literature 16
Ultrasonography of Inflammatory and Structural Lesions in Hand Osteoarthritis: An OMERACT Agreement and Reliability Study 12
Totale 748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022275 0 0 0 136 26 1 2 25 6 5 29 45
2022/2023318 46 101 13 11 0 60 47 3 22 1 13 1
2023/2024130 1 4 41 9 0 4 6 13 6 39 3 4
2024/202525 25 0 0 0 0 0 0 0 0 0 0 0
Totale 748